RICHTER'S TRANSFORMATION
Clinical trials for RICHTER'S TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER'S TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is for people with B-cell blood cancers like lymphoma and leukemia. It tests a new drug, BGB-16673, that breaks down a protein helping cancer grow. The goal is to find the right dose and see if it is safe and shrinks tumors. About 146 people in China will take part.
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New hope for aggressive blood cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a drug called glofitamab, alone or with other medicines, for people with a rare and aggressive form of blood cancer called Richter's transformation. The goal is to see if the treatment can shrink or eliminate the cancer. About 70 adults with this condition will t…
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
New hope for rare aggressive blood cancer: experimental drug enters human trial
Disease control Recruiting nowThis study tests an experimental drug called ONO-4538 in 14 people with Richter's transformation, a rare and aggressive blood cancer that can develop from chronic lymphocytic leukemia. The main goal is to see how many patients' tumors shrink or disappear after treatment. Research…
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Massive new registry tracks 8,000 blood cancer patients for decades
Knowledge-focused Recruiting nowThis study is a long-term registry that follows up to 8,000 people with chronic lymphocytic leukemia (CLL) and similar blood cancers. It does not test any new treatment but instead collects information on survival and disease course over many years. Participants must be 18 or old…
Matched conditions: RICHTER'S TRANSFORMATION
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC